CBER

stack of letters mail envelopes
Marketing

BMS, Novartis, Gilead, Iovance dinged in CBER untitled letters

Promotional materials for a handful of biologics have found their way into the FDA’s hot seat.
Andrea Park Mar 30, 2026 10:00pm
Prasad
Favicon Fierce Biotech

CBER Director Vinay Prasad to depart FDA—again

Mar 6, 2026 5:30pm
Albert Bourla Pfizer CEO Bourla

Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad

Mar 3, 2026 4:58pm
Autoimmune CAR-TNavigating the FDAs new regulatory playbook

Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook

Feb 27, 2026 7:45am
FDA

FDA signs off on 1st gene therapy for rare genetic disease

Dec 10, 2025 12:09pm
Vinay Prasad

FDA's Prasad plans to get tougher on vaccine regulation: memo

Dec 1, 2025 11:25am